Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease

scientific article published on 17 September 2009

Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1164/RCCM.200904-0545OC
P698PubMed publication ID19762563

P50authorCatherine M GreeneQ56915426
P2093author name stringNoel G McElvaney
Shane J O'Neill
Teck Boon Low
P2860cites workInterleukin-32 expression in the pancreasQ28390023
Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjectsQ32035240
Range of antinuclear antibodies in "healthy" individualsQ34065272
Elastin fragments drive disease progression in a murine model of emphysemaQ34338306
IL-32, a proinflammatory cytokine in rheumatoid arthritisQ34480273
Autoantibodies in patients with chronic obstructive pulmonary diseaseQ34584449
Antielastin autoimmunity in tobacco smoking-induced emphysemaQ34621456
Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-ProQ36734881
Induction of lung emphysema is prevented by L-arginine-threonine-arginineQ36841737
Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiencyQ41665649
Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosisQ43759573
Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profileQ43885242
IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.Q44665278
Detection of free antielastin antibodies among diabetic childrenQ46514302
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammationQ46941338
Anti-GAD65 reactive peripheral blood mononuclear cells in the pathogenesis of cystic fibrosis related diabetes mellitusQ59234257
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectinflammationQ101991
autoantibodyQ785022
P304page(s)31-35
P577publication date2009-09-17
P1433published inAmerican Journal of Respiratory and Critical Care MedicineQ4744267
P1476titleAnti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease
P478volume181

Reverse relations

cites work (P2860)
Q38437299A nationwide cohort study of the risk of chronic obstructive pulmonary disease in coeliac disease.
Q38334454A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation
Q33797926A self-propagating matrix metalloprotease-9 (MMP-9) dependent cycle of chronic neutrophilic inflammation
Q33588471A study of chronic obstructive pulmonary disease-specific causes of osteoporosis with emphasis on the emphysema phenotype
Q58840453Anti-Tissue Antibodies Are Related to Lung Function in Chronic Obstructive Pulmonary Disease
Q49222442Autoantibodies in Chronic Obstructive Pulmonary Disease.
Q37990551Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence
Q34172246Autoreactivity to glucose regulated protein 78 links emphysema and osteoporosis in smokers
Q38932311B cells in chronic obstructive pulmonary disease: moving to center stage.
Q33900680CD46 protects against chronic obstructive pulmonary disease.
Q37572312COPD is associated with production of autoantibodies to a broad spectrum of self-antigens, correlative with disease phenotype.
Q41073686Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension
Q27009233Dysfunctional lung anatomy and small airways degeneration in COPD
Q90666512Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury
Q38144104Immune response in chronic obstructive pulmonary disease
Q34126693Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette Smoke
Q37682101Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema
Q37057836Inflammation and immune response in COPD: where do we stand?
Q55479672Interleukin-32: its role in asthma and potential as a therapeutic agent.
Q51536953Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
Q26744356Lung inflammation caused by inhaled toxicants: a review
Q42047048Lung inflammation in COPD: why does it matter?
Q35198950Natural and disease-specific autoantibodies in chronic obstructive pulmonary disease
Q37930203New insights into the immunology of chronic obstructive pulmonary disease.
Q36099465Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease
Q41888256Quantification and evaluation of the role of antielastin autoantibodies in the emphysematous lung
Q34127425Role of th17 cell and autoimmunity in chronic obstructive pulmonary disease
Q89883395Serum Levels of Autoantibodies Against Extracellular Antigens and Neutrophil Granule Proteins Increase in Patients with COPD Compared to Non-COPD Smokers
Q44738347Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
Q97538962Sputum and serum autoantibody profiles and their clinical correlation patterns in COPD patients with and without eosinophilic airway inflammation
Q38294556Targeting immune pathways for therapy in asthma and chronic obstructive pulmonary disease.
Q35987112The lung tissue microbiome in chronic obstructive pulmonary disease
Q42958676The missing link between smoking and COPD autoreactivity?
Q38553419The multiple facets of alpha-1-antitrypsin
Q35042513Update in chronic obstructive pulmonary disease in 2010.

Search more.